Abstract

BackgroundHypoxia-inducible factor 1 (HIF-1α) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1α in tumor cells remain unknown.Methodology/Principal FindingsIn this study, we reported that hypoxia could induce HIF-1α and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1α and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1α expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1α expression.Conclusions/SignificanceTaken together, our study demonstrated that hypoxia-induced HIF-1α expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.

Highlights

  • Angiogenesis is a relatively early event in the progression of human cancer

  • We found that the vascular endothelial growth factor (VEGF) mRNA transcript levels were significantly increased in MCF-7 cells under hypoxia (Fig. 1B)

  • These results indicate that hypoxia can stimulate reactive oxygen species (ROS) generation in breast cancer cells, which acts as the upstream effector of PI3K and extracellular signal-regulated kinase (ERK) in mediating Rac1 activation and HIF-1a expression in hypoxic MCF-7 cells

Read more

Summary

Introduction

Angiogenesis is a relatively early event in the progression of human cancer. A characteristic feature of many human malignancies [7,8], can stimulate the expression of numerous angiogenic factors by the induction of hypoxia-inducible factor-1 (HIF-1), which is a heterodimeric protein composed of HIF-1a and HIF-1b subunits. Hypoxia inhibits HIF-1a hydroxylation and allows its translocation to the nucleus, where it binds to HIF-1b to form an active complex and initiates the transcription of VEGF and other angiogenic factors [9,10,11]. The role of HIF-1a in angiogenesis has been reported, the upstream signaling events stimulating HIF-1a expression activated by hypoxia are still not well characterized. Hypoxia-inducible factor 1 (HIF-1a) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. The molecular mechanisms underlying the induction of HIF-1a in tumor cells remain unknown

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.